Stock News

Does Arsanis Inc (NASDAQ:ASNS) Have Gas After Even Less Sellers Involved?

The stock of Arsanis Inc (NASDAQ:ASNS) registered a decrease of 18.92% in short interest. ASNS’s total short interest was 118,300 shares in November as published by FINRA. Its down 18.92% from 145,900 shares, reported previously. With 183,600 shares average volume, it will take short sellers 1 days to cover their ASNS’s short positions. The short interest to Arsanis Inc’s float is 2.29%.

The stock decreased 4.20% or $0.06 during the last trading session, reaching $1.37. About 857,259 shares traded or 206.93% up from the average. Arsanis, Inc. (NASDAQ:ASNS) has 0.00% since November 10, 2017 and is . It has underperformed by 15.62% the S&P500.

Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody immunotherapies to address serious infectious diseases. The company has market cap of $19.61 million. The Company’s lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. It currently has negative earnings. The company's preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.

Another recent and important Arsanis, Inc. (NASDAQ:ASNS) news was published by Nasdaq.com which published an article titled: “Arsanis Reports Financial Results for Third Quarter 2018” on November 09, 2018.

Arsanis, Inc. (NASDAQ:ASNS) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*